Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Neuromodulators: Making the Right Choice for Your Patient

Douglas Drossman

Cognitive Decline and Aging Panel Discussion

AdventHealth

K. I. Erickson, K. Kennedy, M. Fabiani, L. Oberlin

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Cognitive Disorders

ZINCARE

M. Mataa

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Updates in Dementia

2023 Conference Coverage

P. Tipton

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Use of Novel Biomarkers for Neurodegenerative Diseases in Clinical T…

AD/PD™ International Conference

O. Hansson

Agitation and Alzheimer’s: Strategies for Managing Behavioral and Ps…

Dementia Matters Podcast

N. Chin, H. Kales

Alzheimer's: Clinical Pearls

Lawrence Robbins

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

Microbiome 101: Could Fecal Microbiota Transplants (FMT) Cure Inflam…

Richard Kellermayer

Tiny Plastic Particles, Big Questions for Patient Health

Canadian Society of Allergy and Clinical Immunology

M. Hanna, M. Zemelka-Wiecek

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns

Demystifying Dementia: Differentiating the Most Common Dementias

University of Kansas Medical Center

R. Townley

New & Emerging Treatments in Alzheimer's Disease

University of Miami

E. Crocco